Prudential Financial’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-34,645
| Closed | -$235K | – | 2786 |
|
|
2022
Q1 | $235K | Buy |
34,645
+14,300
| +70% | +$97K | ﹤0.01% | 2473 |
|
|
2021
Q4 | $170K | Buy |
+20,345
| New | +$170K | ﹤0.01% | 2563 |
|
|
2020
Q4 | – | Sell |
-43,850
| Closed | -$358K | – | 2519 |
|
|
2020
Q3 | $358K | Sell |
43,850
-1,490
| -3% | -$12.2K | ﹤0.01% | 2089 |
|
|
2020
Q2 | $312K | Sell |
45,340
-25,293
| -36% | -$174K | ﹤0.01% | 2103 |
|
|
2020
Q1 | $335K | Sell |
70,633
-28,206
| -29% | -$134K | ﹤0.01% | 2034 |
|
|
2019
Q4 | $863K | Sell |
98,839
-33,462
| -25% | -$292K | ﹤0.01% | 1913 |
|
|
2019
Q3 | $440K | Sell |
132,301
-117,933
| -47% | -$392K | ﹤0.01% | 2087 |
|
|
2019
Q2 | $1.24M | Buy |
250,234
+42,011
| +20% | +$208K | ﹤0.01% | 1804 |
|
|
2019
Q1 | $1.29M | Buy |
208,223
+170,268
| +449% | +$1.06M | ﹤0.01% | 1787 |
|
|
2018
Q4 | $127K | Buy |
+37,955
| New | +$127K | ﹤0.01% | 2287 |
|
|
2017
Q3 | – | Sell |
-68,280
| Closed | -$958K | – | 2385 |
|
|
2017
Q2 | $958K | Buy |
+68,280
| New | +$958K | ﹤0.01% | 1849 |
|